A 10-year-old girl who has been battling leukemia for more than four years has become the first person in Taiwan to be successfully treated with a new form of immunotherapy, doctors at National Taiwan University Hospital (NTUH) said yesterday.
The child, identified only as Ting-ting (亭亭), was diagnosed with pediatric B-cell acute lymphoblastic leukemia at the age of six and was initially receiving targeted chemotherapy, her doctors told a news conference.
When her leukemia recurred last year, doctors recommended the CD19 chimeric antigen receptor (CAR) T-cell therapy — a immunotherapy treatment that was introduced in the past decade and had never previously been used successfully to treat a person with leukemia in Taiwan.
Photo: Chiu Chih-jou, Taipei Times
After an infusion of CD19 CAR T-cells in April, Ting-ting’s cancer went into complete remission, the doctors said, adding that she was recently able to spend her 10th birthday at home with her family.
CAR T therapies became prominent in 2012, when they were successfully used in a clinical trial to treat Emily Whitehead, a six-year-old American girl who had been diagnosed with leukemia.
In such therapies, immune cells called T-cells are taken from a patient’s blood and modified by adding a gene for a CAR, which helps them attach to the specific cancer cell antigen. They are then put back in the patient.
Ting-ting’s mother recalled the difficulty she had in explaining the cancer diagnosis to such a young child, telling the news conference that she eventually told her daughter it was “like having a cold” and would get better if she took her medicine.
She thanked her daughter’s medical team for discussing with her the option of CAR T-cell therapy, which she said allowed them to begin the treatment as soon as Ting-ting’s cancer recurred.
Cancer is the second-leading cause of death among children in Taiwan and leukemia accounts for a significant proportion, said Lee Wang-tso (李旺祚), director of NTUH’s Department of Pediatrics.
In the past, the options for treating pediatric leukemia have been limited mainly to chemotherapy, which can cause adverse reactions, and bone marrow transplants, which are difficult to arrange and sometimes require the patient to take immunosuppressant drugs indefinitely, Lee said.
Jou Shiann-tang (周獻堂), a doctor in the hospital’s Department of Hematology and Oncology, said that about 500 new pediatric leukemia cases are diagnosed in Taiwan each year.
About one-quarter of them are acute lymphoblastic leukemia and about 15 percent of such patients have adverse reactions to treatment or the cancer recurs, Jou said.
Ting-ting’s parents said that the CD19 CAR T-cell therapy has the potential to help other children.
However, the treatment is not covered by the National Health Insurance, which meant that they had to sell their home to pay the NT$10 million (US$334,571) it cost.
The National Health Insurance Administration is reviewing whether to cover such treatments in the future, the hospital said.
Considering that most countries issue more than five denominations of banknotes, the central bank has decided to redesign all five denominations, the bank said as it prepares for the first major overhaul of the banknotes in more than 24 years. Central bank Governor Yang Chin-lung (楊金龍) is expected to report to the Legislative Yuan today on the bank’s operations and the redesign’s progress. The bank in a report sent to the legislature ahead of today’s meeting said it had commissioned a survey on the public’s preferences. Survey results showed that NT$100 and NT$1,000 banknotes are the most commonly used, while NT$200 and NT$2,000
The Centers for Disease Control (CDC) yesterday reported the first case of a new COVID-19 subvariant — BA.3.2 — in a 10-year-old Singaporean girl who had a fever upon arrival in Taiwan and tested positive for the disease. The girl left Taiwan on March 20 and the case did not have a direct impact on the local community, it said. The WHO added the BA.3.2 strain to its list of Variants Under Monitoring in December last year, but this was the first imported case of the COVID-19 variant in Taiwan, CDC Deputy Director-General Lin Ming-cheng (林明誠) said. The girl arrived in Taiwan on
ANNUAL EVENT: Two massive Pokemon balloons are to be set up in Daan Park, with an event zone operating from 10am to 6pm This year’s Taipei Floral Picnic is to be held at Daan Park today and tomorrow, featuring an exclusive Pokemon Go event, a themed food market, a coffee rave picnic area and stage performances, the Taipei Department of Information and Tourism said yesterday. Two massive Pokemon balloons are to be set up in the park as attractions, with an exclusive event zone operating from 10am to 6pm, it said. Participants who complete designated tasks on-site would have a chance to receive limited-edition souvenirs, it added. People could also try the newly launched game Pokemon Pokopia in the trial area, the department said. Three PokeStops are
South Korea is planning to revise its controversial electronic arrival card, a step Taiwanese officials said prompted them to hold off on planned retaliatory measures, a South Korean media report said yesterday. A Yonhap News Agency report said that the South Korean Ministry of Foreign Affairs is planning to remove the “previous departure place” and “next destination” fields from its e-arrival card system. The plan, reached after interagency consultations, is under review and aims to simplify entry procedures and align the electronic form with the paper version, a South Korean ministry official said. The fields — which appeared only on the electronic form
RSS